title: Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence?
authors.affiliation: University of Texas Health Science Center, San Antonio, TX, USA. bowdenc@uthsca.edu
authors.forename: Charles
authors.initials: C
authors.lastname: Bowden
authors.forename: Patrice
authors.initials: P
authors.lastname: Boyer
mesh_terms: D000208:Acute Disease; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003431:Cross-Cultural Comparison; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents